Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector.

Autor: Herrlinger, U, Kramm, C M, Aboody-Guterman, K S, Silver, J S, Ikeda, K, Johnston, K M, Pechan, P A, Barth, R F, Finkelstein, D, Chiocca, E A, Louis, D N, Breakefield, X O
Zdroj: Gene Therapy. Jun98, Vol. 5 Issue 6, p809. 11p.
Databáze: Academic Search Ultimate